|
|
||||||||
From the Departments of Epileptology (Drs. Bien and Elger), Radiology (Dr. Urbach), Neuropathology (Drs. Bien, Deckert, and Wiestler), and Neurosurgery (Dr. Schramm), University of Bonn, Germany; and Brain Research Institute (Dr. Lassmann), Department of Neuroimmunology, University of Vienna, Austria.
Address correspondence and reprint requests to Dr. C. Bien, University of Bonn, Department of Epileptology, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany; e-mail: c.bien{at}uni-bonn.de
Objective: To correlate MRI and histopathologic findings in patients with Rasmussens encephalitis (RE).
Patients and methods: MRI features of 10 patients with RE were studied on serial scans. In surgical specimens from these patients, densities of T lymphocytes, microglial cells and nodules, and reactive astrocytes were evaluated.
Results: Densities of T cells, microglial nodules, and astrocytes were inversely correlated to disease duration. MRI abnormalities had a focal onset and spread across one hemisphere. The following course of MRI abnormalities in a given brain region was observed: on very early scans, the cortex was swollen and showed a hyperintense T2/fluid-attenuated inversion recovery signal. Consecutively, progressive atrophy of the affected hemisphere occurred. Correlation of MRI features with quantitative histopathology revealed that there was a higher number of T cells and reactive astrocytes in the earlier MRI stages compared with the late (merely atrophic) stage.
Conclusion: These data suggest a disease course in RE with the highest inflammatory intensity in the early stages and a subsequent decrease in inflammation. The MRI abnormalities and their characteristic sequence may help to identify patients with RE and to obtain informative biopsies.
This article has been cited by other articles:
![]() |
S. Rastogi, C. Lee, and N. Salamon Neuroimaging in Pediatric Epilepsy: A Multimodality Approach RadioGraphics, July 1, 2008; 28(4): 1079 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Bien, T. Granata, C. Antozzi, J. H. Cross, O. Dulac, M. Kurthen, H. Lassmann, R. Mantegazza, J.-G. Villemure, R. Spreafico, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement Brain, March 1, 2005; 128(3): 454 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Urbach, J. Hattingen, J. von Oertzen, C. Luyken, H. Clusmann, T. Kral, M. Kurthen, J. Schramm, I. Blumcke, and H. H. Schild MR Imaging in the Presurgical Workup of Patients with Drug-Resistant Epilepsy AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 919 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Wellard, R. S. Briellmann, J. C. Wilson, R. M. Kalnins, D. P. Anderson, P. Federico, G. C. A. Fabinyi, I. E. Scheffer, A. S. Harvey, and G. D. Jackson Longitudinal study of MRS metabolites in Rasmussen encephalitis Brain, June 1, 2004; 127(6): 1302 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takahashi, H. Mori, M. Mishina, M. Watanabe, T. Fujiwara, J. Shimomura, H. Aiba, T. Miyajima, Y. Saito, A. Nezu, et al. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua Neurology, October 14, 2003; 61(7): 891 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Bien, G. Widman, H. Urbach, R. Sassen, S. Kuczaty, O. D. Wiestler, J. Schramm, and C. E. Elger The natural history of Rasmussen's encephalitis Brain, August 1, 2002; 125(8): 1751 - 1759. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |